New lupus registry tracks Real-World drug safety in 1,000 patients

NCT ID NCT06804057

Recruiting now Knowledge-focused Sponsor: CorEvitas Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is a registry that will follow 1,000 adults with systemic lupus erythematosus (SLE) during their regular doctor visits. Researchers will collect information on how lupus is managed and how patients respond to treatments over time. The goal is to better understand the disease and the safety and effectiveness of current therapies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could provide real-world data on how lupus treatments work and their long-term safety, helping doctors make better treatment decisions.
What could go wrong: This is an observational study, not a controlled trial. It cannot prove cause and effect, and results may be influenced by differences in patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SYSTEMIC LUPUS ERYTHEMATOSUS

Contacts and locations

Show contact details

Locations

CorEvitas
RECRUITING

Waltham, Massachusetts, 02451, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.